Home
Current projects
Methods for valuing health states
Blog
Disease Areas
Arthritis
Cancer
Dermatology
HIV
Obesity
Opthalmology
Publications
Papers
Presentations
Research methods
Economic evaluation
Epidemiology
Meta analysis
Other
Direct to consumer genetic tests
Value of research
Outcome measurement and valuation
Productivity
Year
2001
2004
2005
2006
2007
2008
2009
2010
Subscribe
Healthanomics
A collection of work and information about decision making in health
16 posts:
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis
03.11.2009
Tagged as:
Paper
More details →
Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis
01.11.2009
Tagged as:
Paper
More details →
Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis
01.11.2009
Tagged as:
Paper
More details →
Development of a population-based microsimulation model of osteoarthritis in Canada
23.10.2009
Tagged as:
Paper
More details →
The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
24.09.2009
Tagged as:
Paper
More details →
The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS
01.09.2009
Tagged as:
Paper
More details →
Why do patients with inflammatory arthritis often score states “worse than death” on the EQ-5D? An Investigation of the EQ-5D classification system
01.09.2009
Tagged as:
Paper
More details →
Quality of life of patients with advanced HIV/AIDS: measuring the impact of both AIDS-defining events and non-AIDS serious adverse events
15.08.2009
Tagged as:
Paper
More details →
Economic evaluation of systemic therapies for moderate to severe psoriasis
01.06.2009
Tagged as:
Paper
More details →
Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis
28.04.2009
Tagged as:
Paper
More details →
The Rheumatoid Arthritis Drug Development Model: a case study in Bayesian clinical trial simulation
01.04.2009
Tagged as:
Paper
More details →
Using short-term evidence to predict six-month outcomes in clinical trials of signs and symptoms in rheumatoid arthritis
01.04.2009
Tagged as:
Paper
More details →
Obesity and overweight in Canada: an updated cost-of-illness study
01.04.2009
Tagged as:
Paper
More details →
The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis
25.03.2009
Tagged as:
Paper
More details →
The economics of treatment in early rheumatoid arthritis
01.02.2009
Tagged as:
Paper
More details →
The effect of direct-to-consumer genetic tests on health care utilization and patient welfare
05.07.2010
More details →
Display multiple categories by selecting below
Disease Areas
Arthritis
Cancer
Dermatology
HIV
Obesity
Opthalmology
Publications
Papers
Presentations
Research methods
Economic evaluation
Epidemiology
Meta analysis
Other
Outcome measurement and valuation
Productivity
Year
2001
2004
2005
2006
2007
2008
2009
2010
Most important contributions
Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis
Impact of the recall period on measuring health utilities for acute events
Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis
Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK
Using a discrete choice experiment to estimate societal health state utility values
Translator